Emerging therapies to lower LDL-cholesterol
Prof. Erik Stroes, MD
Prof. Dr. Erik SG Stroes
Chair Department of Vascular Medicine
Academic Medical Center Amsterdam, The Netherlands
Prof. Erik Stroes describes novel therapeutic modalities to lower LDL-cholesterol by other means than statin-induced lowering, either by improving the clearance of LDL-c by inhibiting PCSK9, or by decreasing the production of LDL-c by ApoB antisense or inhibiting MTP. He discusses different mechanisms and presents recent trial results of investigational drugs.
After watching this e-learning, you will know more about:
- alternative options to lower LDL-cholesterol beyond statin therapy
- the drugs in development and their mechanism of action
- recent study results on the efficacy and safety of PCSK9-antibody treatment, ApoB antisense therapy and MTP-inhibitor treatment.